CH663415A5 - Luzopeptin e(2). - Google Patents

Luzopeptin e(2). Download PDF

Info

Publication number
CH663415A5
CH663415A5 CH419/84A CH41984A CH663415A5 CH 663415 A5 CH663415 A5 CH 663415A5 CH 419/84 A CH419/84 A CH 419/84A CH 41984 A CH41984 A CH 41984A CH 663415 A5 CH663415 A5 CH 663415A5
Authority
CH
Switzerland
Prior art keywords
lucopeptin
methionine
luzopeptin
methyl
cysteine
Prior art date
Application number
CH419/84A
Other languages
German (de)
English (en)
Inventor
Charles A Claridge
Henry Schmitz
Terrence William Doyle
Marianne Frances Kammer
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of CH663415A5 publication Critical patent/CH663415A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH419/84A 1983-01-31 1984-01-30 Luzopeptin e(2). CH663415A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US46257783A 1983-01-31 1983-01-31

Publications (1)

Publication Number Publication Date
CH663415A5 true CH663415A5 (de) 1987-12-15

Family

ID=23836950

Family Applications (1)

Application Number Title Priority Date Filing Date
CH419/84A CH663415A5 (de) 1983-01-31 1984-01-30 Luzopeptin e(2).

Country Status (15)

Country Link
JP (1) JPH0645638B2 (fr)
KR (1) KR880001638B1 (fr)
AU (1) AU566569B2 (fr)
BE (1) BE898807A (fr)
CA (1) CA1220746A (fr)
CH (1) CH663415A5 (fr)
DE (1) DE3403125A1 (fr)
FR (1) FR2540116B1 (fr)
GB (1) GB2134119B (fr)
GR (1) GR81749B (fr)
IT (1) IT1175927B (fr)
MY (1) MY8800015A (fr)
NL (1) NL8400237A (fr)
SE (1) SE464582B (fr)
ZA (1) ZA84613B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643871A (en) * 1993-11-23 1997-07-01 Bristol-Meyers Squibb Company Antitumor antibiotics
GB2294265A (en) * 1994-10-20 1996-04-24 Merck & Co Inc Cyclic depsipeptides obtained from Actinomycete sp.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2050384B (en) * 1979-04-02 1983-04-07 Bristol Myers Co Antitumor antibacterial agents

Also Published As

Publication number Publication date
SE464582B (sv) 1991-05-13
JPS59173091A (ja) 1984-09-29
JPH0645638B2 (ja) 1994-06-15
SE8400450L (sv) 1984-08-01
GR81749B (fr) 1984-12-12
GB2134119A (en) 1984-08-08
DE3403125A1 (de) 1984-10-31
AU566569B2 (en) 1987-10-22
FR2540116B1 (fr) 1989-08-18
KR880001638B1 (ko) 1988-09-03
SE8400450D0 (sv) 1984-01-30
NL8400237A (nl) 1984-08-16
IT1175927B (it) 1987-08-12
IT8419348A0 (it) 1984-01-27
BE898807A (fr) 1984-07-31
GB2134119B (en) 1986-04-30
ZA84613B (en) 1984-09-26
FR2540116A1 (fr) 1984-08-03
CA1220746A (fr) 1987-04-21
AU2372184A (en) 1984-08-02
MY8800015A (en) 1988-12-31
GB8402410D0 (en) 1984-02-29
KR840007106A (ko) 1984-12-05

Similar Documents

Publication Publication Date Title
EP0366060B1 (fr) Salbostatine inhibiteur de glycosidase, méthode de sa production et son utilisation
DE3887820T2 (de) Antibiotika, Benanomicine A und B und Dexylosylbenanomicin B, ihre Herstellung und Verwendung.
DE2537902C2 (de) Als Rifamycin P, Q, R und U bezeichnete Antibiotika und Verfahren zu deren Herstellung
DE3521436C2 (fr)
DE3012565A1 (de) Antitumor-antibakterielle mittel
US4536398A (en) Antiviral agents
EP0196628A2 (fr) Antibiotique d'ansamycine, procédé microbiologique pour sa préparation et son utilisation comme médicament
DE2839668C2 (fr)
DE3012014C2 (de) Istamycine, Verfahren zu deren Herstellung sowie Verwendung derselben als antibakterielle Mittel
DE3782169T2 (de) Verfahren zur herstellung von antibiotica 10381b.
DE69816621T2 (de) Macrolide mit antitumoraktivität
CH631740A5 (en) Process for the preparation of maytansinol and its derivatives
US4373028A (en) Culture of Nocardia ATCC 31309
CH663415A5 (de) Luzopeptin e(2).
DE3003359C2 (fr)
DE3136675A1 (de) Neues peptid und dessen herstellung
DE2725163C2 (fr)
DE2746209C2 (fr)
US4003902A (en) Naphthyridinomycin antibiotics
US3839558A (en) Antibiotics a28695a and a28695b and a process for production thereof
CH622823A5 (en) Process for the preparation of antibiotics, namely mimosamycin and chlorcarcins A, B and C
DE2039990C2 (de) Neue Antibiotika B-5050 A bis F (Maridomycin I bis VI), Verfahren zu ihrer Herstellung und ihre pharmazeutische Zubereitung
EP0259778B1 (fr) Dérivé d'acide gentisine efficace antibiotiquement
CH637137A5 (en) Antibiotic and process for its preparation
DE2510868C3 (de) Nanaomycin A und Verfahren zur Herstellung der Antibiorica Nanaomycin A und Nanaomycin B

Legal Events

Date Code Title Description
PL Patent ceased